Literature DB >> 15587920

Effects of pluronic P85 on GLUT1 and MCT1 transporters in the blood-brain barrier.

Elena V Batrakova1, Yan Zhang, Yili Li, Shu Li, Sergei V Vinogradov, Y Persidsky, Valery Yu Alakhov, Donald W Miller, Alexander V Kabanov.   

Abstract

PURPOSE: The amphiphilic block copolymer Pluronic P85 (P85) increases the permeability of the blood-brain barrier (BBB) with respect to a broad spectrum of drugs by inhibiting the drug efflux transporter, P-glycoprotein (Pgp). In this regard, P85 serves as a promising component for CNS drug delivery systems. To assess the possible effects of P85 on other transport systems located in the brain, we examined P85 interactions with the glucose (GLUT1) and monocarboxylate (MCT1) transporters.
METHODS: Polarized monolayers of primary cultured bovine brain microvessel endothelial cells (BBMEC) were used as an in vitro model of the BBB. 3H-2-deoxy-glucose and 14C-lactate were selected as GLUT1 and MCT1 substrates, respectively. The accumulation and flux of these substrates added to the luminal side of the BBMEC monolayers were determined.
RESULTS: P85 has little effect on 3H-2-deoxy-glucose transport. However, a significant decrease 14C-lactate transport across BBMEC monolayers is observed. Histology, immunohistochemistry, and enzyme histochemistry studies show no evidence of P85 toxicity in liver, kidney, and brain in mice.
CONCLUSIONS: This study suggests that P85 formulations do not interfere with the transport of glucose. This is, probably, due to compensatory mechanisms in the BBB. Regarding the transport of monocarboxylates, P85 formulations might slightly affect their homeostasis in the brain, however, without any significant toxic effects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15587920     DOI: 10.1023/b:pham.0000048189.79606.6e

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  24 in total

Review 1.  Radioligand saturation binding experiments over large concentration ranges.

Authors:  D B Bylund; L C Murrin
Journal:  Life Sci       Date:  2000-11-03       Impact factor: 5.037

2.  Expression of various multidrug resistance-associated protein (MRP) homologues in brain microvessel endothelial cells.

Authors:  Y Zhang; H Han; W F Elmquist; D W Miller
Journal:  Brain Res       Date:  2000-09-08       Impact factor: 3.252

3.  Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study.

Authors:  A M Butt; H C Jones; N J Abbott
Journal:  J Physiol       Date:  1990-10       Impact factor: 5.182

4.  Modulation of cultured brain, adrenal, and aortic endothelial cell glucose transport.

Authors:  C G Gaposchkin; J F Garcia-Diaz
Journal:  Biochim Biophys Acta       Date:  1996-12-04

5.  Electron microscopic study of the blood-brain and blood-cerebrospinal fluid barriers with microperoxidase.

Authors:  T S Reese; N Feder; M W Brightman
Journal:  J Neuropathol Exp Neurol       Date:  1971-01       Impact factor: 3.685

6.  Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers.

Authors:  E V Batrakova; S Li; D W Miller; A V Kabanov
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

7.  The role of the efflux transporter P-glycoprotein in brain penetration of prednisolone.

Authors:  A M Karssen; O C Meijer; I C J van der Sandt; A G De Boer; E C M De Lange; E R De Kloet
Journal:  J Endocrinol       Date:  2002-10       Impact factor: 4.286

8.  Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization.

Authors:  E V Batrakova; S Li; S V Vinogradov; V Y Alakhov; D W Miller; A V Kabanov
Journal:  J Pharmacol Exp Ther       Date:  2001-11       Impact factor: 4.030

9.  Optimal structure requirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells.

Authors:  Elena V Batrakova; Shu Li; Valery Yu Alakhov; Donald W Miller; Alexander V Kabanov
Journal:  J Pharmacol Exp Ther       Date:  2003-02       Impact factor: 4.030

10.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

View more
  11 in total

Review 1.  Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Ther Deliv       Date:  2011-08

2.  Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Authors:  A V Kabanov; H E Gendelman
Journal:  Prog Polym Sci       Date:  2007       Impact factor: 29.190

3.  Effect of pluronic p85 on amino acid transport in bovine brain microvessel endothelial cells.

Authors:  Xiaobin Zhang; Daria Y Alakhova; Elena V Batrakova; Shu Li; Zhihui Yang; Yili Li; Alexander V Kabanov
Journal:  J Neuroimmune Pharmacol       Date:  2008-08-02       Impact factor: 4.147

Review 4.  Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 5.  Impact of excipient interactions on drug bioavailability from solid dosage forms.

Authors:  Ravikiran Panakanti; Ajit S Narang
Journal:  Pharm Res       Date:  2012-05-19       Impact factor: 4.200

Review 6.  Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.

Authors:  Sonu Bhaskar; Furong Tian; Tobias Stoeger; Wolfgang Kreyling; Jesús M de la Fuente; Valeria Grazú; Paul Borm; Giovani Estrada; Vasilis Ntziachristos; Daniel Razansky
Journal:  Part Fibre Toxicol       Date:  2010-03-03       Impact factor: 9.400

Review 7.  Agile delivery of protein therapeutics to CNS.

Authors:  Xiang Yi; Devika S Manickam; Anna Brynskikh; Alexander V Kabanov
Journal:  J Control Release       Date:  2014-06-21       Impact factor: 9.776

Review 8.  Nanocarriers for vascular delivery of antioxidants.

Authors:  Elizabeth Hood; Eric Simone; Paritosh Wattamwar; Thomas Dziubla; Vladimir Muzykantov
Journal:  Nanomedicine (Lond)       Date:  2011-09       Impact factor: 5.307

9.  A simple way to enhance Doxil® therapy: drug release from liposomes at the tumor site by amphiphilic block copolymer.

Authors:  Yi Zhao; Daria Y Alakhova; Jong Oh Kim; Tatiana K Bronich; Alexander V Kabanov
Journal:  J Control Release       Date:  2013-03-06       Impact factor: 9.776

10.  Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers.

Authors:  Elena V Batrakova; Shu Li; Anna M Brynskikh; Amit K Sharma; Yili Li; Michael Boska; Nan Gong; R Lee Mosley; Valery Yu Alakhov; Howard E Gendelman; Alexander V Kabanov
Journal:  J Control Release       Date:  2010-01-13       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.